Literature DB >> 25917103

Critical Role of Mast Cells and Peroxisome Proliferator-Activated Receptor γ in the Induction of Myeloid-Derived Suppressor Cells by Marijuana Cannabidiol In Vivo.

Venkatesh L Hegde1, Udai P Singh1, Prakash S Nagarkatti1, Mitzi Nagarkatti2.   

Abstract

Cannabidiol (CBD) is a natural nonpsychotropic cannabinoid from marijuana (Cannabis sativa) with anti-epileptic and anti-inflammatory properties. Effect of CBD on naive immune system is not precisely understood. In this study, we observed that administering CBD into naive mice triggers robust induction of CD11b(+)Gr-1(+) myeloid-derived suppressor cells (MDSC) in the peritoneum, which expressed functional arginase 1, and potently suppressed T cell proliferation ex vivo. Furthermore, CBD-MDSC suppressed LPS-induced acute inflammatory response upon adoptive transfer in vivo. CBD-induced suppressor cells were comprised of CD11b(+)Ly6-G(+)Ly6-C(+) granulocytic and CD11b(+)Ly6-G(-)Ly6-C(+) monocytic subtypes, with monocytic MDSC exhibiting higher T cell-suppressive function. Induction of MDSC by CBD was markedly attenuated in Kit-mutant (Kit(W/W-v)) mast cell-deficient mice. MDSC response was reconstituted upon transfer of wild-type bone marrow-derived mast cells in Kit(W/W-v) mice, suggesting the key role of cKit (CD117) as well as mast cells. Moreover, mast cell activator compound 48/80 induced significant levels of MDSC in vivo. CBD administration in mice induced G-CSF, CXCL1, and M-CSF, but not GM-CSF. G-CSF was found to play a key role in MDSC mobilization inasmuch as neutralizing G-CSF caused a significant decrease in MDSC. Lastly, CBD enhanced the transcriptional activity of peroxisome proliferator-activated receptor γ in luciferase reporter assay, and PPAR-γ selective antagonist completely inhibited MDSC induction in vivo, suggesting its critical role. Together, the results suggest that CBD may induce activation of PPAR-γ in mast cells leading to secretion of G-CSF and consequent MDSC mobilization. CBD being a major component of Cannabis, our study indicates that marijuana may modulate or dysregulate the immune system by mobilizing MDSC.
Copyright © 2015 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25917103      PMCID: PMC4433789          DOI: 10.4049/jimmunol.1401844

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  72 in total

1.  Cannabidiol inhibits inducible nitric oxide synthase protein expression and nitric oxide production in beta-amyloid stimulated PC12 neurons through p38 MAP kinase and NF-kappaB involvement.

Authors:  Giuseppe Esposito; Daniele De Filippis; Maria Chiara Maiuri; Daniela De Stefano; Rosa Carnuccio; Teresa Iuvone
Journal:  Neurosci Lett       Date:  2006-02-21       Impact factor: 3.046

2.  Myeloid-derived suppressor cells inhibit T-cell activation by depleting cystine and cysteine.

Authors:  Minu K Srivastava; Pratima Sinha; Virginia K Clements; Paulo Rodriguez; Suzanne Ostrand-Rosenberg
Journal:  Cancer Res       Date:  2009-12-22       Impact factor: 12.701

3.  Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells.

Authors:  Giovanna Gallina; Luigi Dolcetti; Paolo Serafini; Carmela De Santo; Ilaria Marigo; Mario P Colombo; Giuseppe Basso; Frank Brombacher; Ivan Borrello; Paola Zanovello; Silvio Bicciato; Vincenzo Bronte
Journal:  J Clin Invest       Date:  2006-10       Impact factor: 14.808

Review 4.  PPARgamma, a lipid-activated transcription factor as a regulator of dendritic cell function.

Authors:  Istvan Szatmari; Eva Rajnavolgyi; Laszlo Nagy
Journal:  Ann N Y Acad Sci       Date:  2006-11       Impact factor: 5.691

5.  Peroxisome proliferator-activated receptor gamma ligands stimulate myeloid differentiation and lipogenensis in human leukemia NB4 cells.

Authors:  Etsuko Yasugi; Akiko Horiuchi; Isao Uemura; Emiko Okuma; Masami Nakatsu; Kumiko Saeki; Yasushi Kamisaka; Hiroyuki Kagechika; Kazuki Yasuda; Akira Yuo
Journal:  Dev Growth Differ       Date:  2006-04       Impact factor: 2.053

Review 6.  Combined cannabinoid therapy via an oromucosal spray.

Authors:  Jordi Perez
Journal:  Drugs Today (Barc)       Date:  2006-08       Impact factor: 2.245

7.  The non-psychoactive cannabis constituent cannabidiol is an orally effective therapeutic agent in rat chronic inflammatory and neuropathic pain.

Authors:  Barbara Costa; Anna Elisa Trovato; Francesca Comelli; Gabriella Giagnoni; Mariapia Colleoni
Journal:  Eur J Pharmacol       Date:  2006-11-10       Impact factor: 4.432

Review 8.  Pharmacology of cannabinoid receptor ligands.

Authors:  R G Pertwee
Journal:  Curr Med Chem       Date:  1999-08       Impact factor: 4.530

9.  Reactive oxygen species and 12/15-lipoxygenase contribute to the antiproliferative capacity of alternatively activated myeloid cells elicited during helminth infection.

Authors:  Lea Brys; Alain Beschin; Geert Raes; Gholamreza Hassanzadeh Ghassabeh; Wim Noël; Jef Brandt; Frank Brombacher; Patrick De Baetselier
Journal:  J Immunol       Date:  2005-05-15       Impact factor: 5.422

10.  Mast cells mobilize myeloid-derived suppressor cells and Treg cells in tumor microenvironment via IL-17 pathway in murine hepatocarcinoma model.

Authors:  Zhuoshun Yang; Biao Zhang; Dapeng Li; Meng Lv; Chunmei Huang; Guan-Xin Shen; Bo Huang
Journal:  PLoS One       Date:  2010-01-27       Impact factor: 3.240

View more
  27 in total

1.  Combination of cannabinoids, delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), mitigates experimental autoimmune encephalomyelitis (EAE) by altering the gut microbiome.

Authors:  Zinah Zamil Al-Ghezi; Philip Brandon Busbee; Hasan Alghetaa; Prakash S Nagarkatti; Mitzi Nagarkatti
Journal:  Brain Behav Immun       Date:  2019-07-26       Impact factor: 7.217

2.  MDSCs drive the process of endometriosis by enhancing angiogenesis and are a new potential therapeutic target.

Authors:  Tao Zhang; Juhua Zhou; Gene Chi Wai Man; Kam Tong Leung; Bo Liang; Bo Xiao; Xinting Ma; Shaoyan Huang; Huaxiang Huang; Venkatesh L Hegde; Yin Zhong; Yanmin Li; Grace Wing Shan Kong; Alice Ka Wah Yiu; Joseph Kwong; Pak Cheung Ng; Bruce A Lessey; Prakash S Nagarkatti; Mitzi Nagarkatti; Chi Chiu Wang
Journal:  Eur J Immunol       Date:  2018-03-13       Impact factor: 5.532

3.  Cannabidiol promotes adipogenesis of human and mouse mesenchymal stem cells via PPARγ by inducing lipogenesis but not lipolysis.

Authors:  Richard C Chang; Chloe S Thangavelu; Erika M Joloya; Angela Kuo; Zhuorui Li; Bruce Blumberg
Journal:  Biochem Pharmacol       Date:  2022-01-10       Impact factor: 5.858

Review 4.  Peroxisome proliferator-activator receptor γ and psoriasis, molecular and cellular biochemistry.

Authors:  Xiran Lin; Xianmin Meng; Zhiqi Song; Jingrong Lin
Journal:  Mol Cell Biochem       Date:  2022-03-29       Impact factor: 3.396

5.  Developmental exposure to cannabidiol (CBD) alters longevity and health span of zebrafish (Danio rerio).

Authors:  Zacharias Pandelides; Cammi Thornton; Anika S Faruque; Alyssa P Whitehead; Kristine L Willett; Nicole M Ashpole
Journal:  Geroscience       Date:  2020-03-27       Impact factor: 7.713

6.  Transcriptomic Changes and the Roles of Cannabinoid Receptors and PPARγ in Developmental Toxicities Following Exposure to Δ9-Tetrahydrocannabinol and Cannabidiol.

Authors:  Zacharias Pandelides; Neelakanteswar Aluru; Cammi Thornton; Haley E Watts; Kristine L Willett
Journal:  Toxicol Sci       Date:  2021-07-16       Impact factor: 4.849

7.  CBD Suppression of EAE Is Correlated with Early Inhibition of Splenic IFN-γ + CD8+ T Cells and Modest Inhibition of Neuroinflammation.

Authors:  James M Nichols; Evangel Kummari; Jessica Sherman; Eun-Ju Yang; Saphala Dhital; Christa Gilfeather; Gabriella Yray; Timothy Morgan; Barbara L F Kaplan
Journal:  J Neuroimmune Pharmacol       Date:  2020-05-21       Impact factor: 7.285

8.  Evaluation of Serum Cytokines Levels and the Role of Cannabidiol Treatment in Animal Model of Asthma.

Authors:  Francieli Vuolo; Fabricia Petronilho; Beatriz Sonai; Cristiane Ritter; Jaime E C Hallak; Antonio Waldo Zuardi; José A Crippa; Felipe Dal-Pizzol
Journal:  Mediators Inflamm       Date:  2015-05-25       Impact factor: 4.711

Review 9.  An update on PPAR activation by cannabinoids.

Authors:  Saoirse Elizabeth O'Sullivan
Journal:  Br J Pharmacol       Date:  2016-05-19       Impact factor: 8.739

Review 10.  Cannabis sativa as a Treatment for Obesity: From Anti-Inflammatory Indirect Support to a Promising Metabolic Re-Establishment Target.

Authors:  Eulla Keimili Fernandes Ferreira Cavalheiro; Ana Beatriz Costa; Daniéle Hendler Salla; Mariella Reinol da Silva; Talita Farias Mendes; Larissa Espindola da Silva; Cristini da Rosa Turatti; Rafael Mariano de Bitencourt; Gislaine Tezza Rezin
Journal:  Cannabis Cannabinoid Res       Date:  2021-07-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.